If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


Mergers & Acquisitions

Evonik methacrylates go to Advent International

by Marc Reisch
March 8, 2019 | A version of this story appeared in Volume 97, Issue 10


Evonik Industries has reached a deal to sell its methacrylate business to the private equity firm Advent International for $3.4 billion. Included in the transaction are 18 production sites, 3,900 employees, and acrylic sheet and precursor businesses with annual sales of more than $2 billion. The sale, slated to close by the end of September, also includes CyPlus, a maker of sodium cyanide for refining gold. As part of the deal, Advent gets the well-known Plexiglas brand name globally except in the US, where Arkema owns rights to it. A crowded field of more than 24 firms voiced interest in the business, a source familiar with the process says. Advent’s winning bid came from a field that had narrowed by late February to include Ineos, SK Capital, and a consortium of Rhone Capital and Triton. The deal comes just a year after Evonik said it would sell the methacrylate business to concentrate on less cyclical specialty chemicals. The company plans to use part of the proceeds to fund its $625 million pact, reached in November 2018, to purchase the US hydrogen peroxide maker PeroxyChem and to build a $450 million nylon 12 plant in Marl, Germany.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.